Recent news on Solifenacin

More Patients on Solifenacin Achieved Continence in VENUS Study ...  -  May 8, 2007
DG NewsSAN DIEGO, CA -- May 8, 2007 -- Solifenacin appears to be effective for reducing the symptoms of overactive bladder in patients participating in the

Astellas and Daiichi Sankyo figures fail to dazzle  -  May 16, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder leapt 144.3% to 36.2 billion yen while the antifungal agent Funguard/Mycamine (micafungin) had sales of 16.5

Mitsubishi/Tanabe merger may be first of many in Japan  -  Feb 5, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder also put in a good showing, but Harnal (tamsulosin) for benign prostatic hyperplasia failed to impress after

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
PR Newswire (press release),1 /PRNewswire/ -- Patients with overactive bladder (OAB) treated with VESIcare(R) (solifenacin succinate) experienced statistically significant reductions

Newly Presented Data On VESIcare (R) (solifenacin Succinate) Show ...  -  Dec 1, 2006
Medical News Today (press release),Patients with overactive bladder (OAB) treated with VESIcare(R) (solifenacin succinate) experienced statistically significant reductions in episodes of

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
DG NewsCHRISTCHURCH, NEW ZEALAND -- November 30, 2006 -- Patients with overactive bladder (OAB) treated with VESIcare(R) (solifenacin succinate) experienced

New data on Vesicare show significant improvements in urgency for ...  -  Nov 30, 2006
SpiritIndia,Patients with overactive bladdertreated with Vesicare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency (the

Sección internacional  -  Nov 30, 2006
Bolsamania.com,...(PRN) - Newly Presented Data on VESIcare (R) (solifenacin succinate) Show Significant Improvements in Urgency for Patients With Overactive Bladder ... [+]

New data on Vesicare show significant improvements in urgency for ...  -  Nov 30, 2006
EurekAlert (press release),Christchurch, New Zealand – December 1, 2006 – Patients with overactive bladder (OAB) treated with VESIcare® (solifenacin succinate) experienced

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional